A look at the upcoming winning report from Evaxion Biotech – Evaxion (Nasdaq: Evax)

Evaxion Biotech Eve is preparing to announce her quarterly profits on Tuesday 2025-05-27. Here is a quick overview of what investors should know before the release.

Analysts estimate that Evaxion Biotech one profit per share (EPS) of $ -0.25.

The market is waiting for the announcement of Evaxion Biotech, with the hope high for news about surpassing estimates and offering cheerful guidelines for the next quarter.

It is important for new investors to understand that guidance can be an important engine of stock prices.

Profit performance from the past

In the previous winstrease, the company defeated EPS by $ 0.08, which led to an increase in the share price by 1.81% in the next trade session.

Here is a look at the earlier performance of Evaxion Biotech and the resulting price change:

Market performance of the shares of Evaxion Biotech

Shares of Evaxion Biotech traded at $ 1.87 from 22 May. During the last period of 52 weeks, shares fall by 90.18%. Since these returns are generally negative, shareholders in the long term are probably a bit upset to go into this income release.

To follow all income releases for Evaxion Biotech, visit their profit calendar on our site.

This article was generated by Benzinga’s automated content -engine and assessed by an editor.